Clinical “real‐world” experience with letermovir for prevention of cytomegalovirus infection in allogeneic hematopoietic cell transplant recipients
出版年份 2020 全文链接
标题
Clinical “real‐world” experience with letermovir for prevention of cytomegalovirus infection in allogeneic hematopoietic cell transplant recipients
作者
关键词
-
出版物
CLINICAL TRANSPLANTATION
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2020-04-03
DOI
10.1111/ctr.13866
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Letermovir for Secondary Prophylaxis of Cytomegalovirus Infection and Disease after Allogeneic Hematopoietic Cell Transplantation: Results from the French Compassionate Program
- (2020) Christine Robin et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Lack of a significant pharmacokinetic interaction between letermovir and calcineurin inhibitors in allogeneic HCT recipients
- (2020) Kathryn T. Maples et al. BONE MARROW TRANSPLANTATION
- Interactions between Anti-infective Agents and Immunosuppressants - Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice
- (2019) Tracy Sparkes et al. CLINICAL TRANSPLANTATION
- Letermovir for primary and secondary cytomegalovirus prevention in allogeneic hematopoietic cell transplant recipients: Real‐world experience
- (2019) Andrew Lin et al. Transplant Infectious Disease
- Impact of Cytomegalovirus Viral Load on Probability of Spontaneous Clearance and Response to Preemptive Therapy in Allogeneic Stem Cell Transplantation Recipients
- (2018) Jose F. Camargo et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Role of letermovir for prevention of cytomegalovirus infection after allogeneic haematopoietic stem cell transplantation
- (2018) Raymund R. Razonable CURRENT OPINION IN INFECTIOUS DISEASES
- Reduced-Intensity Conditioning and Dual T Lymphocyte Suppression with Antithymocyte Globulin and Post-Transplant Cyclophosphamide as Graft-versus-Host Disease Prophylaxis in Haploidentical Hematopoietic Stem Cell Transplants for Hematological Malignancies
- (2018) Arjun Datt Law et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Deep functional immunophenotyping predicts risk of cytomegalovirus reactivation after hematopoietic cell transplantation
- (2018) Jose F. Camargo et al. BLOOD
- Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation
- (2017) Francisco M. Marty et al. NEW ENGLAND JOURNAL OF MEDICINE
- Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis
- (2016) P. Teira et al. BLOOD
- Definitions of Cytomegalovirus Infection and Disease in Transplant Patients for Use in Clinical Trials: Table 1.
- (2016) Per Ljungman et al. CLINICAL INFECTIOUS DISEASES
- Epidemiology of infections following haploidentical peripheral blood hematopoietic cell transplantation
- (2016) Michael Slade et al. Transplant Infectious Disease
- Cytomegalovirus viral load and mortality after haemopoietic stem cell transplantation in the era of pre-emptive therapy: a retrospective cohort study
- (2016) Margaret L Green et al. Lancet Haematology
- CMV IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
- (2016) Rafael De la Camara Mediterranean Journal of Hematology and Infectious Diseases
- Impact of Cytomegalovirus Replication and Cytomegalovirus Serostatus on the Outcome of Patients with B Cell Lymphoma after Allogeneic Stem Cell Transplantation
- (2014) Jacopo Mariotti et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- CMV reactivation after allogeneic HCT and relapse risk: evidence for early protection in acute myeloid leukemia
- (2013) M. L. Green et al. BLOOD
- Cytomegalovirus: pathogen, paradigm, and puzzle
- (2011) Michael Boeckh et al. JOURNAL OF CLINICAL INVESTIGATION
- Cytomegalovirus Seroprevalence in the United States: The National Health and Nutrition Examination Surveys, 1988–2004
- (2010) Sheri Lewis Bate et al. CLINICAL INFECTIOUS DISEASES
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started